Senior Director, Clinical Pharmacology
Amylyx PharmaceuticalsSalary not specified
- Full Time
- Senior (5 to 8 years)
$180,000 – $220,000Compensation
Senior (5 to 8 years), Mid-level (3 to 4 years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, Drug Development, BiotechnologyIndustries
Requirements
Candidates should possess broad DMPK experience and expertise spanning target assessment to clinical development, with an awareness of regulatory guidance and industry trends. Leading-edge mindset in relation to current experimental and computational DMPK approaches and techniques, and modeling and simulation expertise is preferred.
Responsibilities
As Director, DMPK, you will provide scientific leadership and strategic guidance, manage activities associated with design, management, analysis, and interpretation of in vitro and in vivo experiments of absorption, distribution, metabolism, and elimination, coordinate and oversee activities supporting compound assessment and advancement, and provide domain area expertise to cross-functional company initiatives. You will also work closely with a team of experienced drug hunters to create novel drug candidates, partner with AI/ML and data scientists to develop a comprehensive PK/ADME prediction platform, identify and manage external providers of ADME and PK services, and drive a cross-functional strategy for capability refinement and expansion.
Skills
Absorption
Distribution
Metabolism
Elimination
In vitro experiments
In vivo experiments
PK/ADME
Modeling
Simulation
Data Science
AI/ML
Drug Discovery
Cross-functional collaboration
Valo Health
Drug discovery using machine learning technology
About Valo Health
Valo Health focuses on drug discovery and development in the biopharmaceutical sector, utilizing advanced technology to create new drugs and therapies. The company employs its proprietary Opal Computational platform, which integrates machine learning, tissue biology, and patient data to streamline the drug discovery process. This platform allows Valo Health to identify potential drug candidates more quickly and accurately than traditional methods. Valo Health differentiates itself from competitors by combining technology with life sciences, fostering a collaborative culture that addresses significant challenges in drug development. The company's goal is to improve health outcomes for patients worldwide by delivering effective solutions through partnerships with pharmaceutical companies and research institutions.
Key Metrics
Boston, MassachusettsHeadquarters
2019Year Founded
$474.2MTotal Funding
LATE_VCCompany Stage
AI & Machine Learning, BiotechnologyIndustries
51-200Employees